RSV-IGIV therapy: a cost/benefit analysis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatrics (Evanston) 1997-09, Vol.100 (3 Pt 1), p.417-418
Hauptverfasser:	Thakur, B K, Wu, L R, Schaeufele, J F
Format:	Artikel
Sprache:	eng
Schlagworte:	Bronchopulmonary Dysplasia - complications Cost-Benefit Analysis Critical Care - economics Hospital Charges Hospitalization - economics Humans Immunoglobulins, Intravenous - administration & dosage Immunoglobulins, Intravenous - adverse effects Immunoglobulins, Intravenous - economics Immunoglobulins, Intravenous - therapeutic use Infant Infant, Newborn Infant, Premature Oxygen Inhalation Therapy - economics Patient Admission - economics Respiration, Artificial - economics Respiratory Syncytial Virus Infections - prevention & control Respiratory Syncytial Viruses Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!